Members of Congress have traded $TMO stock 3 times in the past 6 months. Of those trades, 1 have been purchases and 2 have been sales. Here’s a breakdown of recent ...
Thermo Fisher shares have declined ~20% YTD, presenting an attractive long-term entry point given its resilient business model and broad platform. TMO’s diversified segments, recurring consumables ...
Thermo Fisher Scientific Inc. (NYSE:TMO) is among the best stocks in each sector in 2026. On February 9, Matt Larew, an analyst at William Blair, reiterated a Buy rating on Thermo Fisher Scientific ...
Multiple analysts have issued price targets for $TMO recently. We have seen 12 analysts offer price targets for $TMO in the last 6 months, with a median target of ...
Thermo Fisher Scientific Inc. (TMO), a leading pharmaceutical company in the healthcare sector, is dedicated to accelerating life sciences research and boosting patient health through its life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results